Chlordiazepoxide Hcl And Clidinium Bromide Capsule
Product Images NDC 72162-2436

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Chlordiazepoxide Hcl And Clidinium Bromide (NDC 72162-2436). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chlrodiazepoxideandclidinium-structure.jpg (Chlrodiazepoxideandclidinium Structure)

FDA Label Image

Chlrodiazepoxideandclidinium-structure1.jpg (Chlrodiazepoxideandclidinium Structure1)

FDA Label Image

Label (Lbl721622436)

Label (Lbl721622436)
Each capsule in this medication contains 5 mg of Chlordiazepoxide Hydrochloride USP and 2.5 mg of Clidinium Bromide USP. The usual adult dosage is one or two capsules 3 or 4 times a day, before meals and at bedtime. It is important to keep this medication out of reach of children. For more dosage recommendations and prescribing information, refer to the Package Insert QR Code. Store the capsules at 25°C (77°F) and dispense in a tight, light-resistant container as defined in the USP/NF. Pharmacies can provide the Medication Guide to each patient.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.